Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications.

Caughey GE, Preiss AK, Vitry AI, Gilbert AL, Roughead EE.

Diabetes Care. 2013 Oct;36(10):3009-14. doi: 10.2337/dc12-2197. Epub 2013 Jun 4.

4.

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455.

5.

Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.

Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.

Arch Intern Med. 2009 Aug 10;169(15):1403-10. doi: 10.1001/archinternmed.2009.233. Erratum in: Arch Intern Med. 2009 Sep 28;169(17):1568.

PMID:
19667304
7.

Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.

Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH.

Am J Respir Crit Care Med. 2003 Dec 15;168(12):1488-94. Epub 2003 Oct 2.

PMID:
14525798
8.

Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study.

Lee CH, Lee MC, Shu CC, Lim CS, Wang JY, Lee LN, Chao KM.

BMC Infect Dis. 2013 Apr 30;13:194. doi: 10.1186/1471-2334-13-194.

9.

Inhaled corticosteroids and hospitalisation due to exacerbation of COPD.

Bourbeau J, Ernst P, Cockcoft D, Suissa S.

Eur Respir J. 2003 Aug;22(2):286-9.

10.

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.

PMID:
19948302
11.

Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.

Joo MJ, Au DH, Fitzgibbon ML, Lee TA.

Respir Med. 2010 Feb;104(2):246-52. doi: 10.1016/j.rmed.2009.10.002. Epub 2009 Oct 30.

12.

Does antidepressant medication use affect persistence with diabetes medicines?

Caughey GE, Preiss AK, Vitry AI, Gilbert AL, Ryan P, Shakib S, Esterman A, McDermott RA, Roughead EE.

Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):615-22.

PMID:
23447430
13.

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM.

Curr Med Res Opin. 2009 Jan;25(1):1-13. doi: 10.1185/03007990802534020 .

PMID:
19210134
15.

Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.

Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA.

Curr Med Res Opin. 2009 Nov;25(11):2729-35. doi: 10.1185/03007990903267157.

PMID:
19778165
16.

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.

Ernst P, Gonzalez AV, Brassard P, Suissa S.

Am J Respir Crit Care Med. 2007 Jul 15;176(2):162-6. Epub 2007 Mar 30.

PMID:
17400730
17.

Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.

Lee TA, Schumock GT, Bartle B, Pickard AS.

Pharmacotherapy. 2009 Sep;29(9):1039-53. doi: 10.1592/phco.29.9.1039.

PMID:
19698009
18.

Comparative effectiveness of tiotropium and ipratropium in prevention of hospital readmission for COPD: a population-based cohort study.

Kawasumi Y, Paterson MJ, Morrow RL, Miller TA, Bassett K, Wright JM, Dormuth CR.

Clin Ther. 2013 Apr;35(4):523-531.e1. doi: 10.1016/j.clinthera.2012.10.007. Epub 2013 Mar 13.

PMID:
23490290
19.

Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.

Yawn BP, Li Y, Tian H, Zhang J, Arcona S, Kahler KH.

Int J Chron Obstruct Pulmon Dis. 2013;8:295-304. doi: 10.2147/COPD.S42366. Epub 2013 Jun 27.

20.

Association between incidence of acute exacerbation and medication therapy in patients with COPD.

Suh DC, Lau H, La HO, Choi IS, Geba GP.

Curr Med Res Opin. 2010 Feb;26(2):297-306. doi: 10.1185/03007990903465926.

PMID:
19961283

Supplemental Content

Support Center